The University of Southampton
University of Southampton Institutional Repository

Developing clinical practice guidelines for Chinese herbal treatment of polycystic ovary syndrome: a mixed-methods modified Delphi study

Developing clinical practice guidelines for Chinese herbal treatment of polycystic ovary syndrome: a mixed-methods modified Delphi study
Developing clinical practice guidelines for Chinese herbal treatment of polycystic ovary syndrome: a mixed-methods modified Delphi study
Objectives

Preliminary evidence suggests Chinese herbal medicine (CHM) could be a viable treatment option for polycystic ovary syndrome (PCOS). Prior to conducting a clinical trial it is important to consider the characteristics of good clinical practice. This study aims to use professional consensus to establish good clinical practice guidelines for the CHM treatment of PCOS.

Design and setting

CHM practitioners participated in a mixed-methods modified Delphi study involving three rounds of structured group communication. Round 1 involved qualitative interviews with practitioners to generate statements regarding good clinical practice. In round 2, these statements were distributed online to the same practitioners to rate their agreement using a 7-point Likert scale, where group consensus was defined as a median rating of ?5. Statements reaching consensus were accepted for consideration onto the guideline whilst those not reaching consensus were re-distributed for consideration in round 3. Statements presented in the guidelines were graded from A (strong consensus) to D (no consensus) determined by median score and interquartile range.

Results

11 CHM practitioners in the UK were recruited. After three Delphi rounds, 91 statement items in total had been considered, of which 89 (97.8%) reached consensus and 2 (2.2%) did not. The concluding set of guidelines consists of 85 items representing key features of CHM prescribing for PCOS.

Conclusions

These guidelines can be viewed as an initial framework that captures fundamental principles of good clinical practice for CHM.
chinese herbal medicine, polycystic ovary syndrome, menstrual disorders, delphi, mixed methods
0965-2299
430-438
Lai, Lily
4ad55f3d-3e0c-4faa-a981-cbbbb4319811
Flower, Andrew
5256a2c8-6e74-49be-acc8-463ed3c18c6a
Moore, Michael
1be81dad-7120-45f0-bbed-f3b0cc0cfe99
Lewith, George
0fc483fa-f17b-47c5-94d9-5c15e65a7625
Lai, Lily
4ad55f3d-3e0c-4faa-a981-cbbbb4319811
Flower, Andrew
5256a2c8-6e74-49be-acc8-463ed3c18c6a
Moore, Michael
1be81dad-7120-45f0-bbed-f3b0cc0cfe99
Lewith, George
0fc483fa-f17b-47c5-94d9-5c15e65a7625

Lai, Lily, Flower, Andrew, Moore, Michael and Lewith, George (2015) Developing clinical practice guidelines for Chinese herbal treatment of polycystic ovary syndrome: a mixed-methods modified Delphi study. Complementary Therapies in Medicine, 23 (3), 430-438. (doi:10.1016/j.ctim.2015.03.003). (PMID:26051579)

Record type: Article

Abstract

Objectives

Preliminary evidence suggests Chinese herbal medicine (CHM) could be a viable treatment option for polycystic ovary syndrome (PCOS). Prior to conducting a clinical trial it is important to consider the characteristics of good clinical practice. This study aims to use professional consensus to establish good clinical practice guidelines for the CHM treatment of PCOS.

Design and setting

CHM practitioners participated in a mixed-methods modified Delphi study involving three rounds of structured group communication. Round 1 involved qualitative interviews with practitioners to generate statements regarding good clinical practice. In round 2, these statements were distributed online to the same practitioners to rate their agreement using a 7-point Likert scale, where group consensus was defined as a median rating of ?5. Statements reaching consensus were accepted for consideration onto the guideline whilst those not reaching consensus were re-distributed for consideration in round 3. Statements presented in the guidelines were graded from A (strong consensus) to D (no consensus) determined by median score and interquartile range.

Results

11 CHM practitioners in the UK were recruited. After three Delphi rounds, 91 statement items in total had been considered, of which 89 (97.8%) reached consensus and 2 (2.2%) did not. The concluding set of guidelines consists of 85 items representing key features of CHM prescribing for PCOS.

Conclusions

These guidelines can be viewed as an initial framework that captures fundamental principles of good clinical practice for CHM.

Text
Lai L 2015 Delphi PCOS CHM.pdf - Accepted Manuscript
Download (1MB)

More information

e-pub ahead of print date: 14 March 2015
Published date: June 2015
Keywords: chinese herbal medicine, polycystic ovary syndrome, menstrual disorders, delphi, mixed methods
Organisations: Primary Care & Population Sciences

Identifiers

Local EPrints ID: 378234
URI: http://eprints.soton.ac.uk/id/eprint/378234
ISSN: 0965-2299
PURE UUID: d2a0ac3f-b129-4fbb-aaa3-09c9d4c39524
ORCID for Michael Moore: ORCID iD orcid.org/0000-0002-5127-4509

Catalogue record

Date deposited: 22 Jun 2015 15:25
Last modified: 15 Mar 2024 03:22

Export record

Altmetrics

Contributors

Author: Lily Lai
Author: Andrew Flower
Author: Michael Moore ORCID iD
Author: George Lewith

Download statistics

Downloads from ePrints over the past year. Other digital versions may also be available to download e.g. from the publisher's website.

View more statistics

Atom RSS 1.0 RSS 2.0

Contact ePrints Soton: eprints@soton.ac.uk

ePrints Soton supports OAI 2.0 with a base URL of http://eprints.soton.ac.uk/cgi/oai2

This repository has been built using EPrints software, developed at the University of Southampton, but available to everyone to use.

We use cookies to ensure that we give you the best experience on our website. If you continue without changing your settings, we will assume that you are happy to receive cookies on the University of Southampton website.

×